Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chi

Showing results (801-810 of 903) with videos related to

Pageof 91
Sort By:
Gynecologic Oncology|July 16, 2023
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary studyTiffany Y Sia, Beryl L Manning-Geist, Sarah Ehmann, et al.
Gynecologic Oncology|June 16, 2019
Secondary surgical resection for patients with recurrent uterine leiomyosarcomaPaulina Cybulska, Vasileios Sioulas, Theofano Orfanelli, et al.
Gynecologic Oncology|November 24, 2022
Association of bowel preparation with surgical-site infection in gynecologic oncology surgery: Post-hoc analysis of a randomized controlled trialLea A Moukarzel, Nguyen Nguyen, Qin Zhou, et al.
The Oncologist|August 18, 2009
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancerDennis S Chi, Rebecca Phaëton, Thomas J Miner, et al.
Neuro-Oncology Advances|October 9, 2023
Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patientsAnudeep Yekula, Tiffaney Hsia, Robert R Kitchen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 3, 2026
Assessing the clinical value of pre-operative imaging in endometrial carcinoma by symptoms and low-risk versus high-risk histologyClarissa Lam, Christian Dagher, Vance Broach, et al.
Gynecologic Oncology|January 19, 2016
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer centerJennifer J Mueller, Qin C Zhou, Alexia Iasonos, et al.
Nature Communications|April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarateOvidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.
Gynecologic Oncology|May 23, 2019
Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation statusMarina Stasenko, Paulina Cybulska, Noah Feit, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 1, 2024
A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Thomas Boerner, Michael Kim, et al.
Pageof 91

Showing results (801-810 of 903) with videos related to

Sort By:
Pageof 91
Gynecologic Oncology|July 16, 2023
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary studyTiffany Y Sia, Beryl L Manning-Geist, Sarah Ehmann, et al.
Gynecologic Oncology|June 16, 2019
Secondary surgical resection for patients with recurrent uterine leiomyosarcomaPaulina Cybulska, Vasileios Sioulas, Theofano Orfanelli, et al.
Gynecologic Oncology|November 24, 2022
Association of bowel preparation with surgical-site infection in gynecologic oncology surgery: Post-hoc analysis of a randomized controlled trialLea A Moukarzel, Nguyen Nguyen, Qin Zhou, et al.
The Oncologist|August 18, 2009
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancerDennis S Chi, Rebecca Phaëton, Thomas J Miner, et al.
Neuro-Oncology Advances|October 9, 2023
Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patientsAnudeep Yekula, Tiffaney Hsia, Robert R Kitchen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 3, 2026
Assessing the clinical value of pre-operative imaging in endometrial carcinoma by symptoms and low-risk versus high-risk histologyClarissa Lam, Christian Dagher, Vance Broach, et al.
Gynecologic Oncology|January 19, 2016
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer centerJennifer J Mueller, Qin C Zhou, Alexia Iasonos, et al.
Nature Communications|April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarateOvidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.
Gynecologic Oncology|May 23, 2019
Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation statusMarina Stasenko, Paulina Cybulska, Noah Feit, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 1, 2024
A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Thomas Boerner, Michael Kim, et al.
Pageof 91